Navigation Links
Trouble-shooting: Low yield

  • 72C for 20 seconds for fragments < 500 bp
  • 72C for 40 seconds for fragments 1.2 bp.

    • Suggestion:

    Longer times, not higher temperatures should be used when longer templates or suspected secondary structure is present.

    Back to Top

    Enzyme activity is low

    For Roche Applied Science polymerases, 100% activity is guaranteed through the control date.

    Suggestions:

    1. Check the control date. If necessary, obtain fresh enzyme
    2. Try "Hot start" technique to help retain activity through thermal cycling
    Back to Top Cycle number is too high

    Most templates require 25-30 cycles.

    Suggestion:

    Cycle number should be based on starting concentration of template DNA.

    If the number of target molecules in your sample is...

    Then we recommend the following number of Cycles... 3 x 105 25-30 1.5 x 104 30-35 1.0 x 103 35-40
    '"/>

    Source:


    Page: All 1 2 3 4 5 6 7

    Related biology technology :

    1. Trouble-shooting: Non-specific bands
    2. Trouble-shooting: Misincorporation or low fidelity
    3. Trouble-shooting: No product
    4. Trouble-shooting: Smeared bands
    5. Food science: increasing crop yields
    6. A technique for increasing yields in bioreactors and disposable cell-culture systems
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    		TAG: Trouble shooting Low yield

    (Date:3/11/2010)... at Philadelphia Conference , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced it will ... Bank and Cowen & Company at CBI,s 2010 Accounting and ... attended each year by over 300 finance, accounting, audit and ...
    (Date:3/10/2010)... March 11 Thomson Reuters today announced it has ... Times Higher Education,s influential World University Rankings. The survey reflects ... resource to the global scholarly community. , ... ... ...
    (Date:3/10/2010)... today announced the appointment of Mr. Kevin Giese , President, CEO and Director of BioMS Medical and Mr. Laine Woollard, QC , Senior Legal ... ... , ... ... ...
    (Date:3/10/2010)... , ... ... ... , ... ...
    Breaking Biology Technology:ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 2Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 3Spectral appoints two new board members 2Spectral appoints two new board members 3BR Ventures Invests in Semprae Laboratories 2BR Ventures Invests in Semprae Laboratories 3BR Ventures Invests in Semprae Laboratories 4
    ... Inc.,(Nasdaq: ONTY ) (TSX: ONY) (the "Company") ... in a Phase 1b clinical trial of PX-12 ... proprietary small molecule,inhibitor of thioredoxin, a protein that ... survival and drug resistance of,many cancers., The ...
    ... lecture and present a poster on proprietary siRNA ... targeting ... Quark Pharmaceuticals, Inc., a,development-stage pharmaceutical company discovering and developing ... the Cambridge Healthcare Institute,s 9th Annual Beyond,Genome Conference on ...
    ... DURECT Corporation,(Nasdaq: DRRX ) announced today that ... has been submitted to the U.S. Food,and Drug ... long,acting oral formulation of oxycodone intended to treat ... Remoxy is designed to resist,common methods of prescription ...
    Other Biology Technology:Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 2Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer 3Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 2Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 2New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 4New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 5
    (Date:3/10/2010)... may eventually emerge as a lymphoma treatment, according to ... International Conference on Advances in Cancer Research: From the ... , Lymphoma is a cancer of the immune system ... are then further classified into B-cell and T-cell groups. ... resistant to standard treatment and thus new therapies are ...
    (Date:3/10/2010)... Ala. Discovery of an antibiotic,s capacity to ... movement disorder researchers with leads to more desirable ... of Alabama scientists co-authoring a paper publishing March ... Mechanisms ., "It,s our hope that this ... clinical trial to evaluate the potential of drugs ...
    (Date:3/10/2010)... Scientists have gained new insight into why a relatively ... hearing deficits, long after hearing is restored to normal. ... 11 issue of the journal Neuron , reveals ... auditory cortex is quite vulnerable if it does not ... , It is well established that degraded sensory experience ...
    Breaking Biology News(10 mins):Movement disorder symptoms are lessened by an antibiotic 2Movement disorder symptoms are lessened by an antibiotic 3Research reveals that temporary hearing deprivation can lead to 'lazy ear' 2Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region 59508 1Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region 59508 2ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 1ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 2ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 3ATS Medical Products Featured Prominently at European Association for Cardio Thoracic Surgeons 28EACTS 29 Annual Meeting 5497 4Healthcare Reform Activist Dr Lee Vliet Speaks Out on Healthcare Reform 59505 1Healthcare Reform Activist Dr Lee Vliet Speaks Out on Healthcare Reform 59505 2
    ... major cause of hospital-acquired infections can persist for ... in healthcare settings, including bed linens, computer keyboard ... today at the 105th General Meeting of the ... (MRSA) is a major cause of hospital-acquired infections ...
    ... of two critical proteins that normally shut down during ... the Cold Spring Harbor Laboratory have cured fruit flies ... same proteins-known in short form as CREB and HSP-70--exist ... study results, published online today by the Proceedings of ...
    ... University of Pittsburgh researchers first to report function of ... each other by an extensive network of tiny tunnels ... used to shoot signals to distant cells. This surprising ... of Medicine researchers in the September issue of the ...
    Other Biology News:Huntington's cure in flies lays groundwork for broader treatment approaches 2'Underground' tunnels discovered as means for communication between immune system cells 2'Underground' tunnels discovered as means for communication between immune system cells 3'Underground' tunnels discovered as means for communication between immune system cells 4